New York State Department of Health AIDS Institute (NYSDOH AI) - Division of HIV and Hepatitis Health Care - Bureau of Hepatitis Health Care, and Health Research, Inc. (HRI)
Grants to New York nonprofit health care organizations to increase access to treatment for people suffering from hepatitis C (HCV). Funding is intended for programs that provide access to treatment and care for people with HCV, increase the rate of successful HCV initiation and treatment, and increase the number of people who are cured of HCV. Special consideration will be given to populations that are underserved and socially disadvantaged.
The New York State Department of Health AIDS Institute (NYSDOH AI) Division of HIV and Hepatitis Health Care, Bureau of Hepatitis Health Care, and Health Research, Inc. (HRI) announce the availability funding in New York State (NYS) and federal funding for five (5) years to increase the number of people who are treated and cured for hepatitis C (HCV). As part of New York State’s (NYS’s) plan to eliminate HCV, this will be accomplished by creating a primary care-based integrated multidisciplinary model of care to serve all populations in an equitable manner, especially those currently underserved and socially disadvantaged. Funded applicants will conduct targeted outreach, linkage and care coordination to assist people with HCV, and HIV/HCV in accessing timely HCV medical care and appropriate supportive services in a primary care setting.
To impact the HCV epidemic and move towards elimination, models of care are needed to optimize the HCV care continuum by: outreaching to people who are most at risk and identifying those with HCV; proactively addressing the social and structural barriers that prevent them from engaging in care and prevention; facilitating health systems navigation and patient support; and creating convenient, accessible, multidisciplinary methods of HCV care and treatment delivery.
The goals of this RFA are to:
This will be accomplished by conducting targeted client outreach and recruitment and by providing care coordination, peer-delivered services, and HCV care and treatment utilizing a multidisciplinary care team approach in a primary care setting. Programs are expected to serve all people with HCV in an equitable manner, with attention to ensuring non-discriminatory care to those currently underserved and socially disadvantaged. The priority populations for this RFA are people with mono-infection of HCV and/or co-infection of HIV/HCV. This includes uninsured persons.
Successful applicants will demonstrate their ability to:
For information on program requirements, see page 9 of the RFP attached below.
GrantWatch ID#: 187075
Up to 15 awards
Annual awards will not exceed $300,000.
Funding will be awarded over a period of five years. It is expected that NYS contracts resulting from this RFA will have the following multi-year time period: July 1, 2020 – June 30, 2025.
HRI-funded contracts resulting from this RFA will be for 12-month terms. The anticipated start date of HRI contracts is July 1, 2020. However, depending on the funding source, the initial contract term could be for a shorter time period. HRI awards may be renewed for up to four (4) additional annual contract periods based on satisfactory performance and availability of funds.
Before starting your grant application, please review the funding source's website listed below for updates/changes/addendums/conferences/LOIs.
To apply: https://grantsgateway.ny.gov/IntelliGrants_NYSGG/login2.aspx
Colleen Flanigan, Director Bureau of Hepatitis Health Care
New York State Department of Health/AIDS Institute
USA: New York City; New York